Past event: Biosimilars Commercialisation Summit

The Only Conference With A Dedicated Focus On Planning Your Market Access Strategy and Winning The Race To Market

We know that the competition to get your biosimilar to market first is fierce - and it's only getting fiercer!  So it's never been more essential to perfect your market strategy - ensuring it's  taking into consideration global regulations and healthcare systems, boosting stakeholder confidence and pricing.

Over 3 days of expert case-study presentations, you'll get to listen to insights that will help you to tailor your commercial strategy to penetrate both established and emerging markets.

Worried about your NDA? Don't be. Chatham House Rules will be set for the meeting, and you don't have to mention your strategy at all - this is your space to listen to best practice strategies, and arm yourself with the tools you need to ensure your biosimilar survives in this fierce market.

So join us this May to:

  • Exploit opportunities to broaden patient access by hearing insight from Sandoz and Gedeon Ritcher on how to break into new and emerging markets, with huge scope for economic growth
  • Learn from the experts by hearing panel discussions with Fresenius Kabi, NICE and the NHS to overcome the lack of confidence at each level, in an effort to battle misinformation and ensure a complete, end-to-end strategy
  • Gain a comprehensive knowledge of global healthcare systems and regulatory affairs, giving you the tools to develop a bulletproof and international commercial strategy
  • Understand how both Big Pharma and SMEs successfully launched biosimilars into the European Market in 2019 and avoided competition
  • Start off on the right foot by appreciating the importance of incorporating the supply chain and manufacturing functions into your market access strategy


"Highly valuable to me: excellent networking, broadens my knowledge and gained in-depth access to expertise enabling me to address burning questionable"
Merck

"I'm so glad I did not miss this one! Highly relevant content, very helpful. Overall a high standard of people ready to interact and discuss"
GW Pharmaceuticals

"This event has been inspiring. All participants came in a spirit to learn from each other and to establish a common understanding of requirements"
Shire

Speaker Faculty Members

  • Don Stewart, Chief Executive Officer, PlantForm
  • Julian Sanz, Iberia Market Access Manager Lead (Spain & Portugal), Santen Pharmaceutical
  • Francisco Ballester, President, Latin America, Sandoz
  • Louis Boon, Chief Scientific Officer, Polpharma
  • Jose Carlos Ferreyra, President, Mexican Pharmaceutical Institute
  • Peter Jorgensen, Director, Industrial Association for Generic and Biosimilar Medicines
  • Omar Ali, Advisor on value Based Pricing, US Embassy, Lecturer Value Based Pricing & Outcomes Based Innovative Contracting, University of Portsmouth & Former Member Adoption & Impact Panel, NICE, University of Portsmouth
  • Anna Aillerie, Head Of Commercial Operations, Biotechnology Business Unit, Gedeon Richter
  • Sue Caleo-Naeyaert, Global Head Government Affairs, Policy and Pharmaceconomics, Fresenius Kabi SwissBioSim
  • Kalveer Flora, Specialist Pharmacist Rheumatology and Biosimilars, London North West Healthcare NHS Trust
  • Andreas Herrmann, Chief Executive Officer, Valerius Biopharma AG
  • Fabiola Santillan, Country Manager, TTY Biopharm
  • Lincoln Tsang, Partner, Arnold & Porter Kaye Scholer LLP
  • Simon Keady, EU Market Access Lead - Biosimilars, Biogen
  • Michael Muenzberg, Biosimilars Consultant, Biosimilars Consulting CH
  • Dr Paul Cornes, Oncologist, NHS
  • Paul Calvo, Director, Sterne, Kessler, Goldstein & Fox

Advisory Board Members

  • Michael Muenzberg, Biosimilars Consultant, Biosimilars Consulting CH
  • Stephen Murby, Spokesperson on Biosimilars, International Alliance of Patients' Organizations (IAPO)
  • Duncan Emerton PhD, Independent Biosimilars Consultant, Chester Pharma Ltd

Please fill in your name and email to receive the Conference Agenda of this event.

Conference Day One - 14th May 2019

Conference Day Two - 15th May 2019

Post-Conference Workshop Day - 16th May 2019

Venue

Hotel Novotel Amsterdam Schiphol Airport
Taurusavenue 12, 2132 LS
Hoofddorp, Amsterdam Netherlands

Venue

Hotel Novotel Amsterdam Schiphol Airport
Taurusavenue 12
2132 LS Hoofddorp, Amsterdam
Netherlands
Website: https://www.accorhotels.com/gb/hotel-7060-novotel-amsterdam-schiphol-airport/index.shtml
Phone: +31 20 721 9180

Accommodation
Travel and accommodation are not included in the conference fee; however we have put together a HotelMap that displays discounted accommodation for hotels in the area near to Biosimilars Commercialisation Summit 2019. The map displays live availability and allows you to book directly with each hotel: https://www.HotelMap.com/pro/MXLSN

Please note: We will never recommend, approve or appoint any third party rooming service to act on our behalf. Please be extremely wary if you are approached by any such companies. We will always endeavour to negotiate the best available rates for you so please use the HotelMap link provided; this shows live availability and rates for all hotels in the area and allows you to book directly with the hotel of your choice within your budget.
Event details
Organizer : IQEU
Event type : Conference
Reference : ASDE-20268